Zevra Therapeutics, Inc. Proceeds from Sale of Productive Assets
Zevra Therapeutics, Inc. (ZVRA) reported Proceeds from Sale of Productive Assets of $2.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2016-03-16
- Zevra Therapeutics, Inc. proceeds from sale of productive assets for the quarter ending 2014-12-31 was $0.00.
- Zevra Therapeutics, Inc. proceeds from sale of productive assets for fiscal 2014 was $2.00K, a 88.24% decline from fiscal 2013.
- Zevra Therapeutics, Inc. proceeds from sale of productive assets for fiscal 2013 was $17.00K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $2.00K 10-K · filed 2016-03-16 | |
| 2014-09-30 | $2.00K 10-Q · filed 2015-11-13 | ||
| 2013-12-31 | $17.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |